Research programme: dementia therapy - China Botanic PharmaceuticalAlternative Names: Senile dementia therapy - China Botanic Pharmaceutical; Siberian Ginseng (Acanthopanax) Total Glucosides Total Flavanoids Soft Capsule - China Botanic Pharmaceutical
Latest Information Update: 16 Jul 2016
At a glance
- Originator China Botanic Pharmaceutical
- Class Alternative medicine
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Dementia
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Dementia in China (PO, Capsule)
- 31 Jul 2011 Preclinical trials in Dementia in China (PO)